Recent literature on fibrinolysis

Recent Literature on Fibrinolysis Low-fat, high-fiber diet favorably affects several independent riskmarkers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Dams. Marckmann P; Sandstrom B; Jespersen J. Am J Clin Nutr Apr 1994, 59 (4) p935-9 Hypofibrinolysis: a common, major cause of osteonecrosis. Glueck CJ; Freiberg R, Glueck HI; Henderson C; Welch M; Tracy T; Stroop D ; Hamer T, Sosa F; Levy M. Am J Hematol Feb 1994,45 (2) p156-66 Beta blockers, Lp(a), hypertension, and reduced basal librinolytic activity. Glueck CJ, Glueck HI; Hamer T; Speirs J; Tracy T, Stroo D. Am J Med Sci May 1994,307 (5) p3 17-24 Prostacyc f!m is required for t-PA release after venous occlusion. Iacoviello L; De Curtis A; D’Adamo MC, Amore C; Buczko W; De Gaetano G1 Donati MB. Am J Physiol Feb 1994,266 (2 Pt 2) pH429-34 Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury [see comments]. Idell S; Kumar A, Koenig KB; Coalson JJ. Am J Respir Crit Care Med Mar 1994, 1.49 (3 pt l)p767_75 Impaired tibrmo ysis m the hemolytic-uremic syndrome of childhood. Menzel D; Levi M; Dooijewaard G; Peters M; ten Cate JW. Ann Hematol Jan 1994,68 (1) ~43-8 [Intensification ofthe effect of exogenous lasminogen activators on lysis of fibrin blood clots due to a Becrease in the level of alpha-2- antiplasmin by a plasmaso tion method]. Usilenie deistviia ekzogennykh aktivatorov p‘pazmmogena na lizis tibrinovykh sgustkov iz plazmy za schet snizheniia urovnia alpha-2-antiplazmina metodom plazmosorbtsii. Ogloblina OG, Saburova OS; Semenova OA; Belova LA. Biokhimiia Jan 1994,59 (1) ~62-8 Evaluation ofthe thrombolytic effect of tissue-type plasminogen activator with uhrasomc irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Kimura M; Iijima S; Kobayashi K; Furuhata H. Biol Pharm Bull Jan 1994, 17 (1) ~126-30 [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex]. Ingibirovanie L-lizinom esteraznoi, aktivatomoi i tibrinoliticheskoi aktivnosti aktivatomogo kompleksa plazminstreptokinaza. Aisina RB, Gaisarian ES; Snitko IaE, Vartolomeev SD. Bioorg Khim Feb 1994,20 (2) pl82-9 Uncoupling fibrin from integrin receptors hastens Iibrinolysis at the platelet-fibrin interface. Bra&en JV, Jerome WG, Hantgan RR. Blood Feb 15 1994,83 (4) p982-93 Clivarin and other LMWHs in an ex vivo cardiopulmonary bypass model. Studies on contact activation. Heller W; Wendel HP. Blood Coagul Fibrinolysis Dee 1993,4 Suppl 1 pS45-54 The influence of tamoxifen in viva on the main natural anticoagulants and fibrinol [..sis. Pemberton KD; Melissari E; Kakkar VV. Blood Coagu Fibrmolysis Dee 1993, 4 (6) p93542 Fibrinolytic parameters during acute haematemesis in endemic hepatosplenomegal Omran SA; el-Bassiouni NE; Amer AM; Hussein AT. Bloo B Coagul Fibrmolysis Dee 1993, 4 (6) p8914 Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding: relation to diagnosis and blood transfusion treatment. Henriksson AE; Nilsson TK; Svensson JO. Blood Coagul Fibrinolysis Dee 1993,4 (6) ~877-80 Circadian variation m tibrinolytic activity in patients with variant an ina. Masuda T, Ogawa H; Miyao Y; Yu Q; Misumi I; Ss amoto T, Okubo H; Okumura K; Yasue H. Br Heart J Feb 1994,71 (2)p156-61 Decreased contact factor mediated tibrinolysis in cirrhosis. Cohen H, Hunt JB; Dixit M; Kanwar S; Thomas HC. Br J Haematol Nov 1993,85 (3) ~542-5 Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Orchard MA; Goodchild CS; Prentice CR, Davies JA; Benoit SE; CreightonKemsford LJ, GatIiiey PJ; Michelson AD. Br J Haematol Nov 1993,85 (3) ~533-41 Fibrinolysis in the rat lung after intravenous tumour cell injection. Peterson HI; Risberg B. Cancer L&t Mar 1977,2 (4-5) ~191-4 Fibrinolysis-resistant fibrin deposits in minor labial salivary glands of patients with Sjo ren’s syndrome. Zeher M, Szegedi G, Csiki Z; Cseh A; A f any R. Clin Immunol Immunopathol May 1994,71 (2)pl49-55 Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Kapiotis S; Quehenberger P; Eichler HG, Schwarzinger I; Partan C; Schneider B; Iechner K; Speiser W. Crit Care Med Apr 1994,22 (4) ~606-12 Biochemical pro erties of variant plasminogens associated with thrombophi .Pia: defective bindmg and activation of variant plasminogens on the surface of monocytoid U937 cells. Kozlowski KA: Berlet A: Robbins KC. Fibrinolvsis Mav, 1994. , ’ 8 (3) ~135-46 ’ A comparison of librinol ic capacity and res onse to TNF-alpha stimulation in the cu ftured endothelial ce 1 lmes ECV 304 and

EA.hy 926. Martin NB; Jamieson A; Rutter H; Tufftn DP. Fibrinolysis May 1994,. 8 (3) ~147-55 Fibrinolytic changes in mahgnant ascites. Oh D, Hwang SG, Hong SY; Suh CI; Lee HB; Kye KC; Park S; Kim NK. Fibrinolysis in synovial fluid of Carmassi F.; De Negri F, Morale M; Puccetti R, Song KY, Chung SI. Fibrmolysis May 1994,8 Route(3)P162-71. o activation, in vitro? ofthe factor XII-dependent pathway of librinolysis. Kluh C; Jie AF. Fibrinolysis May 1994, 8 (3) ~172-6 Expression of a human PAI- fusion peptide in E. coli and its immunochemical characterization. Swiatkowska M, Stec WJ; Plucienniczak A; Ciemiewski CS. Fibrinolysis May 1994, 8 (3)p177-81 Heparin as an hyperbolic modulator of plasminogen activation by tPA. Pirie-Shepherd SR, Blasco E; Pizza SV. Fibrinolysis May 1994,8 (3) ~182-8 Anti-streptokinase (SK) IgG remains low following local SKtherapy compared to mtravenous coronary thrombolysis with SK. Breuning L, Tvedskov J; Munkvad S. Fibrinolysis May 1994. 8 (3)0189-91 \-jr--Activation of pro-urokinase by cathepsin G in the presence of glucosammoglycans. Drag B; Petersen LC. Fibrinolysis May 1994.8 (3) 0192-9 Activation oft& contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. Cugno M, Cicardi M, Agostoni A. J Allergy Clin Immunol May 1994,93 (5) ~870-6 Cutaneous and plasma fibrinolytic activities are not deficient in patients with systemic sclerosis [letter]. Lotti T, Campanile G, Matucci-Cerinic M. J Am Acad Dermatol May 1994, 30 (5 Pt 1) ~813-4 Effect of nafamostat mesilate on coagulation and ftbrinolysis in hepatic resection. Shimada M; Matsumata T, Shirabe K, Kamakura T, Taketomi A; Sugimachi K. J Am Coil Surg May 1994, 178 (5) p498-502 The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis. Horrevoets AJ; Smilde A; de Vries C; Pannekoek H. J Biol Chem Apr 29 1994,269 (17) p12639-44 Production of prostacyclin and fibrinolysis modulators by endothelial cells cultured in the presence of pal ethylene terephthalate. Cenni E; Ciapetti G, Cavedagna 1;; Di Leo A; Pizzoferrato A. J Biomed Mater Res Sep 1993,27 (9) ~1161-4 Indirect strong inhibition by acid-stable trypsin-plasmin inhibitor (ASTPI) ofthe activations of elastase and plasma fibrinolysis in a dog model of acute pancreatitis. Sumi H, Eto Y. J Enzym Inhib 1993,7 (2)p131-6 von Willebrand factor and tibrinolytic variables are differently affected in the insulin resistance syndrome. Nilsson TK, Boman K; Bjerle P, Hallmans G, Hellsten G. J Intern Med May 1994,235 (5)p419-23 Modulation of postsurgical cell infiltration and Iibrinolytic activity by tolmetin in two species. Rodgers KE; Ellefson DD; Girgis W; diZerega GS. J Surg Res Apr 1994, 56 (4)p314-25 Modulation of the tibrinolytic system by major peripheral ischemia. Schneiderman J; Eguchi Y, Adar R, Sawdey M. J Vast Surg Mar 1994, 19 (3) ~516-24 [The effect of the Ion -term use of a diet enriched with omega-3 polyunsaturated Patty acids on the fatty acid composition, tibrinolytic system indices and lipid spectrum ofthe blood in patients with ischemic heart disease]. Vliianie dlitel’nogo primeneniia diety, obogashchennoi omega-3 oolinenasvshchennvmi zhimvmi kislotami. na zhimokislotnvi $ostav, pdkazateli hbrinoliticheskoi sistemy i lipidnyi spek& krovi u bol’nykh ishemicheskoi bolezn’iu serdtsa. Pyzh MV; Gratsianskii NA, Dobrovol’skii AB. Kardiologiia 1993,33 (10) ~46-50, 5-6 Stress-dependent changes in fibrinolysis, serotonin and platelet aggre ation in rats. Malyszko J, Urano T; Takada Y; Takada A. Li ze SCI 1994, 54 (17) ~1275-80 Physiological consequences of loss of lasminogen activator gene function in mice. Carmeliet P; SCRoonJans L, Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC. Nature Mar 3 1 1994, 368 (6470) p419-24 Transarterial Iibrinolysis using tissue plasminogen activator in a atient with acute renal failure due to acute thrombosis of g.dateral renal arteries. 3 years’ follow-up [letter]. Takeda M; Katayama Y; Takahashi H; Saito K; Tsutsui T; Komeyama T; Sato S. Nephron 1994,66 (2) ~240-1 [Coa p... ulation and tibrinolysis systems in bronchoalveolar lavage f uid m nradtated lung of rabbits]. Sawada M. Nippon Kyobu Shikkan Gakkai Zasshi Dee 1993,3 1 (12) 15 15-2 1 [Disorders of coagulationitibrinolysis and blee I mg tendency]. Endo T; Amemiya N; Kume S. Nippon Rinsho Jan 1994,52 (1) pl19-23 I

f.

B9

Blood librinolysis and the response to desmopressin in glomemlone hritis. Brommer EJ; Van den Wall Bake AW; Dooijewaar B G, van Loon BJ; Emeis JJ; Weening JJ. Thromb Haemost Jan 1994,71 (1) gl9-25 Attenuatmg efIect of anttthrom m III on the tibrinolytic activation and microvascular derangement in rat gastric mucosa. Kurose I; Miura S; Fukumura D; Suzuki M, Nagata H; Sekizuka E, Morishita T; Tsuchiya M. Thromb Haemost Jan 1994,71 (1) ~119-23 Parameters of librinolysis in peritoneal fluid and plasma in different stages of the menstrual cycle. Dorr PJ, Brommer EJ, Dooijewaard G, Vemer WM. Thromb Haemost Nov 15 1993, 70 (5) ~873-5 Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength. Rijken DC; de Munk GA; Jie AF. ‘Ihromb Haemost Nov 15 1993,70 (5) ~867-72 Inhibition of endothelial cell expression of plasminogen activator inhibitor type-l by gemtibrozil. Fujii S; Sawa H, Sobel BE. Ihromb Haemost Ott 18 1993,70 (4) ~642-7 [The effect of urokinase inhibitors on effective librinolytic activity of human urine]. Vliianie ingibitorov urokinazy na effektivnuiu librinoliticheskuiu aktivnost’ mochi liudei. Potapenko VE; Shataeva LK. Vopr Med Khim Jan-Feb 1994, 40 (1) ~37-8,

[The librinolytic system and total parenteral nutrition]. Sistema fibrinolitico y nutrition parenteral total. Femandez Ruiz M; Lasierra Cirujeda J. Nutr Hosp Dee 1993,X (9) ~574-9 [Correlation between thrombocytes and librinolysis]. A thrombocytak es a tibrinolysis kapcsolata. Udvardy M; Posan E, Rak K. On, Hetil Mar 27 1994, 135 (13) ~677-80 [Selected parameters of coagulation, trbrinolysis and antibodies to fibrinogen in lung cancer]. Wybrane parametry krzepmecra I librynolizy oraz przeciwciaLa przeciwfibrynogenowe w raku pluca. Kondera-Anasz Z; Gisman K; Mertas A. Pneumonol Alergol Pal 1993,61 (9-10) ~461-6 [Erythropoietin and Iibrinolysis in uremic patients]. Erytropoetyna a ukLad tibrynolityczny u chorych na mocznice. MaLyszko J; Pawlak K; Mazerska M; MaLyszko J; Mysliwiec M. Pol Arch Med Wewn Ott 1993,90 (4) ~267-9 [Anticoagulant and librinolytic systems of the injured vascular endothelial cellsl. Takeva H: Suzuki K. Rinsho Bvori _ Aor . 1994,42 (4) ~33’3-9 ’ ’ Hybridization to an anti-activated platelet monoclonal antibody enhances fibrinolytic potency on urokinase. Du L; Yu RR, Hua ZC; Zhu DX; Wu GX; Ruan CG. Sci China B Dee 1993,36 (12)p1483-9 Effect of rabbit activated protein C on thrombin tjeneration and tibrinolysis in a species-specific in vivo mo el: eRect of modulation of protein S activity. Weinstein RE; Walker FJ. Semin Thromb Hemost 1993, 19 (4) ~368-77

Bibliography prepared from MEDLINE! by the British Library Medical Information Centre, covering the June to August 1994 files.

BlO